One Test Will Never Tell the Whole Story

• by Russ Lebovitz

• September 29, 2026

Photodynamic therapy gains FDA approval for superficial BCC

Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.

• by Kathryn Wighton

• September 15, 2026

• 2 min

Rare Disease AI Puts Variants in Focus

aiDIVA combines genomic evidence, phenotype matching, machine learning, and language models

• September 24, 2026

• 3 min

ECP 2026: Is HPV-Specific Testing Optimized in Throat Cancer?

Cost and turnaround times are a potential challenge to standardization of testing and optimization of patient pathways

• September 14, 2026

• 2 min